fluorobenzenes has been researched along with Psychotic Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corso, T; Dziewiatkowski, J; Hesse, RA; Klejbor, I; Kucinski, A; Miletich, R; Moryś, J; Rice, KC; Spodnik, JH; Stachowiak, EK; Stachowiak, MK; Wersinger, SR | 1 |
| Bonhaus, DW; McFarland, K; Price, DL | 1 |
| Hammond, B; Hussain, I; Kew, JN; Stean, TO; Upton, N; Virley, DJ; Waters, KA | 1 |
| Marona-Lewicka, D; Nichols, DE; Thisted, RA | 1 |
| De Hert, M; Hanssens, L; Kalnicka, D; Peuskens, J; Scheen, A; Van Eyck, D; van Winkel, R; Wampers, M | 1 |
| Carlsson, ML | 1 |
| Adams, HR; Carson, RE; Channing, MA; Der, MG; Eckelman, WC; Herscovitch, P; Jagoda, E; Watabe, H | 1 |
7 other study(ies) available for fluorobenzenes and Psychotic Disorders
| Article | Year |
|---|---|
Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Exploratory Behavior; Female; Fluorobenzenes; Gait Disorders, Neurologic; Grooming; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Piperidines; Protein-Tyrosine Kinases; Psychotic Disorders; Rats; Receptors, Fibroblast Growth Factor; Reflex, Startle; Serotonin; Serotonin Antagonists; Social Behavior | 2009 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea | 2011 |
Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Cognition; Disease Models, Animal; Fluorobenzenes; Locomotion; Male; Phencyclidine; Phenols; Piperidines; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Recognition, Psychology; Serotonin Antagonists; Sulfonamides | 2012 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2005 |
Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Cardiovascular Diseases; Dyslipidemias; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Psychotic Disorders; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Schizophrenia; Sulfonamides; Treatment Outcome | 2006 |
The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis.
Topics: Animals; Biogenic Monoamines; Disease Models, Animal; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; Mice, Inbred Strains; Neurotransmitter Agents; Piperazines; Piperidines; Psychomotor Performance; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Muscarinic; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1995 |
Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907.
Topics: Animals; Blood Pressure; Brain; Carbon Radioisotopes; Depression; Fluorobenzenes; Heart Rate; Ligands; Macaca mulatta; Models, Biological; Piperidines; Psychotic Disorders; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tomography, Emission-Computed | 2000 |